Interpretation of social organization standard of Specification for Pathological Diagnosis of Tuberculosis

doi:10.19982/j.issn.1000-6621.20240074

Abstract

Abstract:

The social organization standard Specification for Pathological Diagnosis of Tuberculosis (T/CRHA 029—2023) was officially released on the national group standard platform on December 25, 2023, and was implemented from January 1, 2024. This article interprets the core points of the standard, aiming to assist pathologists at all levels of medical institutions nationwide in mastering the basis of pathological diagnosis of tuberculosis and improving their diagnostic proficiency in this area.

Key words: Tuberculosis, Pathology, Diagnosis, differential, Comment

CLC Number:

Zhao Yanli, Che Nanying. Interpretation of social organization standard of Specification for Pathological Diagnosis of Tuberculosis[J]. Chinese Journal of Antituberculosis, 2024, 46(4): 371-374. doi: 10.19982/j.issn.1000-6621.20240074

Figures/Tables 1

References 13

[1]	World Health Organization. Global tuberculosis report 2023. Geneva: World Health Organization, 2023.
[2]	World Health Organization. Global tuberculosis report 2022. Geneva: World Health Organization, 2022.
[3]	中华医学会结核病学分会, 结核病病理学诊断专家共识编写组. 中国结核病病理学诊断专家共识. 中华结核和呼吸杂志, 2017, 40(6): 419-425. doi:10.3760/cma.j.issn.1001-0939.2017.06.005.
[4]	宋婧, 车南颖. 结核病分子病理学诊断技术临床应用进展. 中国防痨杂志, 2018, 40(11): 1221-1225. doi:10.3969/j.issn.1000-6621.2018.11.014.
[5]	中国研究型医院学会. T/CRHA 029—2023 结核病病理学诊断规范. 2023-12-25.
[6]	World Health Organization. WHO consolidated guidelines on tuberculosis. Module 4: treatment drug-susceptible tuberculosis treatment. Geneva: World Health Organization, 2022.
[7]	李红娜, 毛昕, 徐碧宇, 等. 常见原位病理染色技术诊断肺结核的临床价值研究. 中国防痨杂志, 2023, 45(5): 477-482. doi:10.19982/j.issn.1000-6621.20220537.
[8]	王铭, 王雪晴, 王国庆, 等. 荧光定量PCR在石蜡标本结核杆菌检测中的应用价值. 诊断病理学杂志, 2022, 29(9): 877-878. doi:10.3969/j.issn.1007-8096.2022.09.028.
[9]	Chopra KK, Sidiq Z, Hanif M, et al. Advances in the diagnosis of tuberculosis-Journey from smear microscopy to whole genome sequencing. Indian J Tuberc, 2020, 67(4S): S61-S68. doi:10.1016/j.ijtb.2020.09.026. pmid: 33308673
[10]	Lee RS, Proulx JF, Mcintosh F, et al. Previously undetected super-spreading of Mycobacterium tuberculosis revealed by deep sequencing. Elife, 2020, 9:e53245. doi:10.7554/eLife.53245.
[11]	Ndhlovu V, Mandala W, Sloan D, et al. Evaluation of the efficacy of two methods for direct extraction of DNA from Mycobacterium tuberculosis sputum. J Infect Dev Ctries, 2018, 12(12): 1067-1072. doi:10.3855/jidc.10592.
[12]	张美兰, 沈哲式, 张英哲, 等. 实时荧光定量PCR方法在石蜡包埋组织中结核分枝杆菌检测意义. 吉林医学, 2018, 39(9):1633-1635. doi:10.3969/j.issn.1004-0412.2018.09.012.
[13]	范月玲, 王春蒲, 高建伟, 等. 2019—2020年山西省临汾市结核病分子生物学核酸检测技术应用情况分析. 中国防痨杂志, 2021, 43(12): 1280-1286. doi:10.3969/j.issn.1000-6621.2021.12.009.

[1]	Xu Chenyi, Chen Hui, Zhong Jiyuan, Ding Xiaoyan, Yang Rui, Xu Xiangchao, Zhang Canyou, Cheng Jun, Li Tao. Investigation on the status of tuberculosis infection among household student close contacts of pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 375-382.
[2]	Chen Ruiqi, Zhang Mingwu, Wang Wei, Chen Songhua, Liu Zhengwei, Chen Bin. Prevalence and influencing factors of latent tuberculosis infection among elderly rural residents in Changshan County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 383-389.
[3]	Fan Xiaolei, Maiwulajiang·Yimamu , Peng Xiaowang, Hu Pengyuan, Wang Yanjie, Alimire·Abulimiti , Mairihaba·Kamili , Wang Senlu, Xiang Yang. Analysis of the incidence and influencing factors of household close contacts of pulmonary tuberculosis patients in Kashgar, Xinjiang Uygur Autonomous Region, 2018—2021 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 390-396.
[4]	Teng Chong, Wang Yulan, Liu Liu, Zhang Fang, Huang Fei, Li Tao, Zhao Bing, Zhao Yanlin, Ou Xichao. Analysis of the epidemiological characteristics and prediction for the reported incidence of pulmonary tuberculosis in Dongcheng District, Beijing from 2013 to 2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 397-402.
[5]	Yang Chao, Wang Jing, Yang Chaohui, Gao Hanqing. Analysis of the epidemiological characteristics and treatment outcomes of pulmonary tuberculosis aged ≥60 years old in Tongzhou District of Beijing, 2016—2022 [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 403-410.
[6]	Li Xueqiu, Kuang Haobin, Wang Ting, Min Fei, Tao Lan, Cao Xihui, Li Xiang, Liu Guobiao. Analysis of self-paid medical expenses and influencing factors for multidrug-resistant tuberculosis patients in Guangzhou City [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 411-417.
[7]	Wang Liyan, Zhou Hui, Wu Qian, Hao Xiaogang, Lu Bingxin, Chen Bin. Evaluation of the implementation effect of the “Zero Burden” strategy for diagnosis and treatment of pulmonary tuberculosis in Longyou County, Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 418-423.
[8]	Zhou Shuang, Zong Di, Li Shixue, Du Jian. Analysis of influencing factors of tuberculosis patients’ medical experience with the internet hospital platform [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 424-432.
[9]	Ni Shuaihu, Wang Jia, Chen Gang, Dong Longyu, Wang Ni, Luo Xiaofeng, Qu Yan, ZhaoYanlin . Analysis of the influence of receiving health education on knowledge, belief and behavior of college students in four provinces in China [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 433-439.
[10]	Li Yang, Chen Bin, Peng Ying, Chen Xinyi, Jiang Jianmin. Investigation and analysis of social discrimination and awareness of pulmonary tuberculosis among junior college students in Zhejiang Province [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 440-448.
[11]	Shang Xuetian, Dong Jing, Huang Mailing, Sun Qi, Jia Hongyan, Zhang Lanyue, Liu Qiuyue, Yao Mingxu, Wang Yingchao, Ji Xiuxiu, Du Boping, Xing Aiying, Pan Liping. Transcriptome study on peripheral blood mononuclear cells of latent tuberculosis infection individuals [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 449-460.
[12]	Zheng Hailun, Li Yamin, Sun Shanhua, He Xiaoxin. Analysis of influencing factors on treatment interruption in 317 pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 467-472.
[13]	Wen Shufang, Wei Rongrong, Li Haoran, Liu Yi. The role of CD4⁺ and CD8⁺T cells in the immune response to tuberculosis [J]. Chinese Journal of Antituberculosis, 2024, 46(4): 479-484.
[14]	Pei Shaojun, Ou Xichao. Interpretation of the World Health Organization’s Catalogue of mutations in Mycobacterium tuberculosis complex and their association with drug resistance (2nd Edition) [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 260-266.
[15]	Zhu Limei. Thoughts on improving the tuberculosis screening policy in diabetes patients in China [J]. Chinese Journal of Antituberculosis, 2024, 46(3): 267-271.